Condition

Refractory Schizophrenia

ClinicalTrials.gov condition label

Clinical trials8

Recruiting1

Common interventions12

Lead sponsors shown7

Clinical trials

8 shown

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in AdultsNCT03094429 · 2017-03-29

Deep Brain Stimulation of the Nucleus Accumbens and Anterior Limb of the Internal Capsule in the Treatment of Refractory SchizophreniaNCT07369401 · 2026-01-20

NOT_YET_RECRUITING

The Synergistic Effect of Hypoglycemic Index Diet on Refractory SchizophreniaNCT04302636 · 2019-09-24

Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in SchizophreniaNCT04352569 · 2016-05-03

Deep Brain Stimulation in Treatment Resistant SchizophreniaNCT02377505 · 2013-01-01

Occupational Therapy in the Rehabilitation of Executive Functions in Patients With SchizophreniaNCT01879956 · 2012-02-01

Electroconvulsive Therapy (ECT) in Patients With Super Refractory SchizophreniaNCT02049021 · 2010-02-01

Repetitive Transcranial Magnetic Stimulation for Refractory Auditory Hallucinations in SchizophreniaNCT01386918 · 2004-02-01

Common interventions

Craft ActivitiesOTHER1 Deep Brain StimulationDEVICE1 Low glycemic index dietDIETARY_SUPPLEMENT1 MECTA SPECTRUM 5000Q ECTDEVICE1 NaBen®DRUG1 Off-StimulationDEVICE1 OGI MethodBEHAVIORAL1 On-StimulationDEVICE1 PlaceboOTHER1 repetitive Transcranial Magnetic StimulationDEVICE1 Sham ECTPROCEDURE1 transcranial direct current stimulationDEVICE1

Leading sponsors

University of Sao Paulo2 Centre for Addiction and Mental Health1 Centre hospitalier de Ville-Evrard, France1 First Affiliated Hospital of Fujian Medical University1 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1 Shanghai Jiao Tong University School of Medicine1 SyneuRx International (Taiwan) Corp1

Trial status mix

COMPLETED3

UNKNOWN3

NOT_YET_RECRUITING1

RECRUITING1

Phase mix

NA6

PHASE21

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.